Victory Capital Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Victory Capital Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-28,368	Closed	-$1.36M	–	3724
2020 Q1	$1.36M	Buy	28,368 +11,941	+73%	+$555K	﹤0.01%	1743
2019 Q4	$771K	Buy	16,427 +3,437	+26%	+$152K	﹤0.01%	1828
2019 Q3	$307K	Buy	+12,990	New	+$385K	﹤0.01%	2067

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Victory Capital Management's RARX Position: Q2 2020 in Review

Victory Capital Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 28,368 shares — an estimated $1.36M sold.

Victory Capital Management first reported a position in RARX in Q3 2019 and held it in 3 quarters. The position peaked at $1.36M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Victory Capital Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Victory Capital Management sold 28,368 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $1.36M.
Victory Capital Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
Victory Capital Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $1.36M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.